Evidence map›Paper›PMID 23911438›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2013

Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome.

Xiaoguang Sun, Shwu-Fan Ma, Michael S Wade, Marialbert Acosta-Herrera, Jesús Villar, Maria Pino-Yanes, Tong Zhou, Bin Liu, Patrick Belvitch, Jaideep Moitra and 8 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The acute respiratory distress syndrome biomarker pipeline: crippling gaps between discovery and clinical utility.Translational research : the journal of laboratory and clinical medicine · 2020
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Xiaoguang SunInstitute for Personalize Respiratory Medicine, Univ. of Illinois at Chicago, 3099 COMRB (MC719 909 S. Wolcott Ave., Chicago, IL 60612. jggarcia@uic.edu.
Shwu-Fan Ma
Michael S Wade
Marialbert Acosta-Herrera
Jesús Villar
Maria Pino-Yanes
Tong Zhou
Bin Liu
Patrick Belvitch
Jaideep Moitra
Yoo-Jeong Han
Roberto Machado
Imre Noth
Viswanathan Natarajan
Steven M Dudek
Jeffrey R Jacobson
Carlos Flores
Joe G N Garcia
University of Illinois Chicago · USUniversity of Chicago · USHospital Universitario Nuestra Señora de Candelaria · ESHospital Universitario de Gran Canaria Doctor Negrín · ESInstituto de Salud Carlos III · ES

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI STEVEN M DUDEK · 2016 to 2026
$24.4M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
Regulation of Asthmatic Inflammation by Non-Muscle MLCKR01HL091889 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GARCIA, JOE G. N., WANG, TING · 2008 to 2018
$3.2M
Pulmonary and Critical Care Post-Doctoral Research Training ProgramT32HL082547 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FINN, PATRICIA W · 2007 to 2017
$2.7M
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS P01 HL058064NHLBI NIH HHS P01 HL098050NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R01 HL091889NHLBI NIH HHS T32 HL082547NIGMS NIH HHS GM07019
6 · The paper itself

Abstract

The genetic mechanisms underlying the susceptibility to acute respiratory distress syndrome (ARDS) are poorly understood. We previously demonstrated that sphingosine 1-phosphate (S1P) and the S1P receptor S1PR3 are intimately involved in lung inflammatory responses and vascular barrier regulation. Furthermore, plasma S1PR3 protein levels were shown to serve as a biomarker of severity in critically ill ARDS patients. This study explores the contribution of single nucleotide polymorphisms (SNPs) of the S1PR3 gene to sepsis-associated ARDS. S1PR3 SNPs were identified by sequencing the entire gene and tagging SNPs selected for case-control association analysis in African- and ED samples from Chicago, with independent replication in a European case-control study of Spanish individuals. Electrophoretic mobility shift assays, luciferase activity assays, and protein immunoassays were utilized to assess the functionality of associated SNPs. A total of 80 variants, including 29 novel SNPs, were identified. Because of limited sample size, conclusive findings could not be drawn in African-descent ARDS subjects; however, significant associations were found for two promoter SNPs (rs7022797 -1899T/G; rs11137480 -1785G/C), across two ED samples supporting the association of alleles -1899G and -1785C with decreased risk for sepsis-associated ARDS. In addition, these alleles significantly reduced transcription factor binding to the S1PR3 promoter; reduced S1PR3 promoter activity, a response particularly striking after TNF-α challenge; and were associated with lower plasma S1PR3 protein levels in ARDS patients. These highly functional studies support S1PR3 as a novel ARDS candidate gene and a potential target for individualized therapy.

Indexed as

Promoter Regions, GeneticBase SequenceBiomarkersCase-Control StudiesElectrophoretic Mobility Shift AssayFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansLysophospholipidsMaleMiddle AgedMolecular Sequence DataPolymorphism, Single NucleotideReceptors, LysosphingolipidBiomarkersLysophospholipidsReceptors, LysosphingolipidSphingosinesphingosine 1-phosphatesphingosine-1-phosphate receptor-3, humanSphingosine-1-Phosphate Receptorsacute respiratory distress syndromeassociation studydisease predispositionsingle nucleotide polymorphismsphingosine 1-phosphate

Identifiers

PMID23911438
PMCPMC4073968
OpenAlexW2023293039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.